DAFTAR PUSTAKA Abbas SA, Glazier JJ, Wu AH, Dupont C, Green ...

DAFTAR PUSTAKA 

Abbas SA, Glazier JJ, Wu AH, Dupont C, Green SF, Pearsall LA, Waters DD, 

McKay RG. Factors associated with the release of cardiac troponin T 

following percutaneous transluminal coronary angioplasty. Clin Cardiol 

1996;19:782–786. 

Abdelmeguid AE, Ellis SG, Sapp SK, Whitlow PL, Topol EJ. Defining the 

appropriate threshold of creatine kinase elevation after percutaneous 

coronary interventions. Am Heart J 1996;131:1097–1105. 

Ahmed JM, Mintz GS, Weissman NJ, Lansky AJ, Pichard AD, Satler LF, Kent 

KM. Mechanism of lumen enlargement during intracoronary stent 

implantation: an intravascular ultrasound study. Circulation 2000;102:7– 

10. 

Ajani AE, Waksman R, Sharma AK, Lew R, Pinnow E, Canos DA, Cheneau E, 

Castagna M, Cha DH, Leborgne L, Satler LF, Pichard AD, Kent KM, 

Lindsay J. Usefulness of periprocedural creatinine phosphokinase-MB 

release to predict adverse outcomes after intracoronary radiation therapy 

for instent restenosis. Am J Cardiol 2004;93:313–317. 

Akkerhuis KM, Alexander JH, Tardiff BE, Boersma E, Harrington RA, Lincoff 

AM, Simoons ML. Minor myocardial damage and prognosis: are 

spontaneous and percutaneous coronary intervention-related events 

different? Circulation 2002;105:554–556. 

Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined— 

a consensus document of the Joint European Society of 

Cardiology/American College of Cardiology Committee for the 

redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959–969. 

Baim DS, Cutlip DE, Sharma SK, Ho KK, Fortuna R, Schreiber TL, Feldman RL, 

Shani J, Senerchia C, Zhang Y, Lansky AJ, Popma JJ, Kuntz RE. Final 

results of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation 

1998;97:322–331. 

Universitas Sumatera Utara

Bonderman D, Teml A, Jakowitsch J, Adlbrecht C, Gyongyosi M, Sperker W, 

Lass H, Mosgoeller W, Glogar DH, Probst P, Maurer G, Nemerson Y, 

Lang IM. Coronary no-reflow is caused by shedding of active tissue factor 

from dissected atherosclerotic plaque. Blood 2002;99:2794–2800. 

Bonz AW, Lengenfelder B, Jacobs M, Strotmann J, Held S, Ertl G, Voelker W. 

Cytokine response after percutaneous coronary intervention in stable 

angina: effect of selective glycoprotein IIb/IIIa receptor antagonism. Am 

Heart J 2003;145:693–699. 

Brener SJ, Ellis SG, Schneider J, Topol EJ. Frequency and long-term impact of 

myonecrosis after coronary stenting. Eur Heart J 2002; 23:869–876. 

Cavallini C, Savonitto S, Violini R, dkk. Impact of the elevation of biochemical 

markers on myocardial damage on longterm mortality after percutaneous 

coronary intervention: results of the CK-MB and PCI study. Eur Heart J 

2005;26:1494-8. 

Choi JW, Gibson CM, Murphy SA, Davidson CJ, Kim RJ, Ricciardi MJ. 

Myonecrosis following stent placement: association between impaired 

TIMI myocardial perfusion grade and MRI visualization of 

microinfarction. Catheter Cardiovasc Interv 2004;61:472–476. 

Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN. Enhanced 

extracellular matrix accumulation in restenosis of coronary arteries after 

stent deployment. J Am Coll Cardiol 2002;40:2072–2081. 

Dehmer GJ, Nichols TC, Bode AP, Liles D, Sigman J, Li S, Koch G, Tate DA, 

Griggs TR. Assessment of platelet activation by coronary sinus blood 

sampling during balloon angioplasty and directional coronary 

atherectomy. Am J Cardiol 1997;80:871–877. 

Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon 

MB. Effect of rotational atherectomy in noncalcified atherosclerotic plaque: a 

volumetric intravascular ultrasound study. J Am Coll Cardiol 1996;28:856–860. 

Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ. Death following 

creatine kinase-MB elevation after coronary intervention: identification of 

an early risk period: importance of creatine kinase-MB level, completeness 


of revascularization, ventricular function, and probable benefit of statin 

therapy. Circulation 2002;106:1205-10. 

Feldman T, Oldroyd KG, Preda I, Holmes DR, Colombo A, Morice MC, Leadley 

K, Dawkins KD, Mohr FW, Serruys PW. Staged percutaneous coronary 

intervention in SYNTAX study: three years outcome. J Am Coll Cardiol 

2011;57:E1886. 

Fuchs S, Kornowski R, Mehran R, dkk. Prognostic value of cardiac troponin-I 

levels following catheter-based coronary interventions. Am J Cardiol 

2000;85:1077-82. 

Garbarz E, Iung B, Lefevre G, Makita Y, Farah B, Michaud P, Graine H, 

Vahanian A. Frequency and prognostic value of cardiac troponin I 

elevation after coronary stenting. Am J Cardiol 1999;84:515–518. 

Gibson CM, Murphy SA, Marble SJ, Cohen DJ, Cohen EA, Lui HK, Young J Jr, 

Kitt MM, Lorenz TJ, Tcheng JE. Relationship of creatine kinase– 

myocardial band release to thrombolysis in myocardial infarction 

perfusion grade after intracoronary stent placement: an ESPRIT substudy. 

Am Heart J 2002;143:106–110. 

Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, 

Giugliano RP, Cannon CP, Antman EM, Braunwald E; TIMI Study 

Group. Association between duration of tirofiban therapy before 

percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 

substudy). Am J Cardiol 2004;94:492–494. 

Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, 

Wexberg P, Zorn G, Glogar D, Probst P, Maurer G, Huber K. Plasma 

levels of C-reactive protein after coronary stent implantation. Eur Heart J 

2000;21:1152–1158. 

Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, Satler LF, 

Lansky AJ, Stone GW, Leon MB. Clinical outcome following 

percutaneous coronary interventions in patients with chronic renal failure. 

Catheter Cardiovasc Interv 2002;55:66–72. 

Gurm HS, Bhatt DL, Gupta R, Ellis SG, Topol EJ, Lauer MS. Preprocedural 

white blood cell count and death after percutaneous coronary intervention. 

Am Heart J 2003;146:692–698. 


Harrington RA, Lincoff AM, Califf RM, Holmes DR Jr, Berdan LG, O’ Hanesian 

MA, Keeler GP, Garratt KN, Ohman EM, Mark DB, Jacobs AK, Topol 

EJ. Characteristics and consequences of myocardial infarction after 

percutaneous coronary intervention: insights from the Coronary 

Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J Am Coll 

Cardiol 1995;25:1693–1699. 

Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 

2005;26:2493-519. 

Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Kent KM, 

Satler LF, Stone GW, Leon MB. Creatine kinase-MB enzyme elevation 

following successful saphenous vein graft intervention is associated with 

late mortality. Circulation 1999;100:2400–2405. 

Iijima R, Tsunoda T, Yamamoto M, Shiba M, Wada M, Tsuji T, Yamamoto M, 

Nakajima R, Yoshitama T, Hara H, Hara H, Nakamura M. Fate of 

unprotected side branches as related to embolic complications during stent 

implantation for acute coronary syndromes using a distal protection 

procedure. Am J Cardiol 2005;95:636–639. 

Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of 

activation process of platelets and neutrophils after coronary stent 

implantation versus balloon angioplasty for stable angina pectoris. Am J 

Cardiol 2000;86:1057–1062. 

Ioannidis JP, Karvouni E, Katritsis DG. Mortality risk conferred by small 

elevations of creatine kinase-MB isoenzyme after percutaneous coronary 

intervention. J Am Coll Cardiol 2003;42:1406–1411. 

Kini A, Marmur JD, Kini S, Dangas G, Cocke TP, Wallenstein S, Brown E, 

Ambrose JA, Sharma SK. Creatine kinase-MB elevation after coronary 

intervention correlates with diffuse atherosclerosis, and low-tomedium 

level elevation has a benign clinical course: implications for early 

discharge after coronary intervention. J Am Coll Cardiol 1999; 34:663– 

671. 

Kini AS, Lee P, Mitre CA, Duffy ME, Sharma SK. Postprocedure chest pain after 

coronary stenting: implications on clinical restenosis. J Am Coll Cardiol 

2003;41:33–38. 


Klein LW, Kern MJ, Berger P, Sanborn T, Block P, Babb J, Tommaso C, 

Hodgson JM, Feldman T. Society of cardiac angiography and 

interventions: suggested management of the no-reflow phenomenon in the 

cardiac catheterization laboratory. Catheter Cardiovasc Interv 

2003;60:194–201. 

Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance 

of transient creatine kinase elevations and the diagnosis of non-Q wave 

myocardial infarction associated with coronary angioplasty. J Am Coll 

Cardiol 1991;17:621–626. 

Koch KC, vom Dahl J, Kleinhans E, Klues HG, Radke PW, Ninnemann S, Schulz 

G, Buell U, Hanrath P. Influence of a platelet GPIIb/IIIa receptor 

antagonist on myocardial hypoperfusion during rotational atherectomy as 

assessed by myocardial Tc-99 m sestamibi scintigraphy. J Am Coll 

Cardiol 1999;33:998–1004. 

Kong TQ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO. 

Prognostic implication of creatine kinase elevation following elective 

coronary artery interventions. JAMA 1997;277:461–466. 

Kugelmass AD, Cohen DJ, Moscucci M, Piana RN, Senerchia C, Kuntz RE, Baim 

DS. Elevation of the creatine kinase myocardial isoform following 

otherwise successful directional coronary atherectomy and stenting. Am J 

Cardiol 1994;74:748–754. 

Leadley K. How to calculate the SYNTAX score. Cardiac Intervenstions 

Today;2009:32-35. 

Levine GN, Kern MJ, Berger PB, Brown DL, Klein LW, Kereiakes DJ, Sanborn 

TA, Jacobs AK. Management of patients undergoing percutaneous 

coronary revascularization. Ann Intern Med 2003;139:123–136. 

Lim CCS, van Gaal WJ, Testa L, dkk. With the ―universal definition,‖ 

measurement of creatinine kinase-myocardial band rather than troponin 

allows more accurate diagnosis of periprocedural necrosis and infarction 

after coronary intervention. J Am Coll Cardiol 2011;57:653-61. 

Mahmud E, Shaw KD, Penny WF. Patients at low risk for periprocedural 

myocardial infarction can be identified by assessment immediately 


following percutaneous coronary intervention. J Invasive Cardiol 

2003;15:343–347. 

Mandadi VR, DeVoe MC, Ambrose JA, Prakash AM, Varshneya N, Gould RB, 

Nguyen TH, Geagea JP, Radojevic JA, Sehhat K, Barua RS. Predictors of 

troponin elevation after percutaneous coronary intervention. Am J Cardiol 

2004;93:747–750. 

Mansour M, Carrozza JP Jr, Kuntz RE, Fishman RF, Pomerantz RM, Senerchia 

CC, Safian RD, Diver DJ, Baim DS. Frequency and outcome of chest pain 

after two new coronary interventions (atherectomy and stenting). Am J 

Cardiol 1992;69:1379–1382. 

McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O’Donnell MJ, DeFranco 

AC, Meengs WL, McNamara R, McGinnity JG, Patel K, Share D, Riba A, 

Khanal S, Moscucci M. Blue Cross Blue Shield of Michigan 

Cardiovascular Consortium (BMC2). Prognostic implication of anemia on 

in-hospital outcomes after percutaneous coronary intervention. Circulation 

2004;110:271–277. 

Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB. Axial plaque 

redistribution as a mechanism of percutaneous transluminal coronary 

angioplasty. Am J Cardiol 1996;77:427–430. 

Ong AT, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous 

coronary intervention with TAXus and cardiac surgery (SYNTAX) study: 

design, rationale, and run-in phase. Am Heart J. 2006;151:1194-1204. 

Oh JK, Shub C, Ilstrup DM, Reeder GS. Creatine kinase release after successful 

percutaneous transluminal coronary angioplasty. Am Heart J 

1985;109:1225–1231. 

Prasad A, Herrmann J. M. Myocardial infarction due to percutaneous coronary 

intervention. N Engl J Med 2011;364:453-64. 

Rahman AM. Angina pektoris stabil. Dalam : Buku Ajar Ilmu Penyakit Dalam 

Jilid II, editor Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, 

Edisi 5, Interna Publishing 2009. 


Ravkilde J, Nissen H, Mickley H, Andersen PE, Thayssen P, Horder M. Cardiac 

troponin T and CK-MB mass release after visually successful 

percutaneous transluminal coronary angioplasty in stable angina pectoris. 

Am Heart J 1994;127:13–20. 

Ricchiuti V, Shear WS, Henry TD, Paulsen PR, Miller EA, Apple FS. Monitoring 

plasma cardiac troponin I for the detection of myocardial injury after 

percutaneous transluminal coronary angioplasty. Clin Chim Acta 

2000;302:161–170. 

Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, 

Bonow RO. Troponin I elevation and cardiac events after percutaneous 

coronary intervention. Am Heart J 2003;145:522–528. 

Robbins MA, Marso SP, Wolski K, Peterson J, Lincoff AM, Brener S. Chest 

pain—a strong predictor of adverse cardiac events following precutaneous 

intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting 

Trial [EPISTENT]). Am J Cardiol 1999;84:1350–1353. 

Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, 

Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, 

Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. 

Creatine kinase-MB elevation after percutaneous coronary intervention 

predicts adverse outcomes in patients with acute coronary syndromes. Eur 

Heart J 2004;25:313–321. 

Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Association of systemic 

inflammatory state with troponin I elevation after elective uncomplicated 

percutaneous coronary intervention. Am J Cardiol 2002;89:981–983. 

Sanchez-Margalet V, Cubero JM, Martin-Romero C, Cubero J, Cruz-Fernandez 

JM, Goberna R. Inflammatory response to coronary stent implantation in 

patients with unstable angina. Clin Chem Lab Med 2002;40:769–774. 

Saucedo JF, Mehran R, Dangas G, Hong MK, Lansky A, Kent KM, Satler LF, 

Pichard AD, Stone GW, Leon MB. Long-term clinical events following 

creatine kinase– myocardial band isoenzyme elevation after successful 

coronary stenting. J Am Coll Cardiol 2000;35:1134–1141. 


Serrano CV Jr, Ramires JA, Venturinelli M, Arie S, D’Amico E, Zweier JL, 

Pileggi F, da Luz PL. Coronary angioplasty results in leukocyte and 

platelet activation with adhesion molecule expression: evidence of 

inflammatory responses in coronary angioplasty. J Am Coll Cardiol 

1997;29:1276–1283. 

Serruys PW, Garg S. Clinical implications of the SYNTAX study. 2008.Available 

from: Touch briefings. http://www.touchcardiology.com/articles/clinicalimplications-syntax-study. 

Accesed 31 March 2011. 

Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention 

versus coronary artery bypass grafting for severe coronary artery disease. 

N Engl J Med. 2009;360:961-972. 

Shyu KG, Kuan PL, Cheng JJ, Hung CR. Cardiac troponin T, creatine kinase, and 

its isoform release after successful percutaneous transluminal coronary 

angioplasty with or without stenting. Am Heart J 1998;135:862–867. 

Sianos G, Morel MA, Kappetein AP, dkk. The SYNTAX score: an angiographic 

tool grading the complexity of coronary artery disease. EuroIntervention 

2005;1:219-27. 

Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz 

RE, Popma JJ, Schaff HV, Williams DO, Gibbons RJ, Alpert JP, Eagle 

KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith 

SC Jr. ACC/AHA guidelines of percutaneous coronary interventions 

(revision of the 1993 PTCA guidelines)—executive summary. A report of 

the American College of Cardiology/American Heart Association Task 

Force on Practice Guidelines (committee to revise the 1993 guidelines for 

percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 

2001;37:2215–2239. 

Smith SC Jr, Feldman TE, Hirshfeld JW Jr, dkk. ACC/AHA/SCAI 2005 guideline 

update for percutaneous coronary intervention: a report of the American 

College of Cardiology/American Heart Association Task Force on Practice 

Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 

Guidelines for Percutaneous Coronary Intervention). Circulation 

2006;113(7):e166-e286. 

Stankovic G, Chieffo A, Iakovou I, Orlic D, Corvaja N, Sangiorgi G, Airoldi F, 

Colombo A. Creatine kinase–myocardial band isoenzyme elevation after 


percutaneous coronary interventions using sirolimuseluting stents. Am J 

Cardiol 2004;93:1397–1401. 

Tardiff BE, Califf RM, Tcheng JE, Lincoff AM, Sigmon KN, Harrington RA, 

Mahaffey KW, Ohman EM, Teirstein PS, Blankenship JC, Kitt MM, 

Topol EJ. Clinical outcomes after detection of elevated cardiac enzymes in 

patients undergoing percutaneous intervention. IMPACT-II Investigators. 

Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary 

Thrombosis-II. J Am Coll Cardiol 1999;33:88–96. 

Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. 

Eur Heart J 2007;28:2525-38. 

van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The Syntax score predicts 

peri-procedural myocardial necrosis during percutaneous coronary 

intervention. Int J Cardiol 2009;135:60 –5. 

Versaci F, Gaspardone A, Tomai F, Proietti I, Crea F, Chiariello L, Gioffre PA. 

Chest pain after coronary artery stent implantation. Am J Cardiol 

2002;89:500–504. 

Zairis MN, Ambrose JA, Ampartzidou O, Lyras AG, Manousakis SJ, 

Makrygiannis SS, Beldekos DJ, Devoe MC, Fakiolas CN, Prekates AA, 

Olympios CD, Argyrakis SK, Foussas SG. Preprocedural plasma Creactive 

protein levels, postprocedural creatine kinase-MB release, and 

longterm prognosis after successful coronary stenting (four-year results 

from the GENERATION study). Am J Cardiol 2005;95:386–390.

DAFTAR PUSTAKA Abbas SA, Glazier JJ, Wu AH, Dupont C, Green ...

Create successful ePaper yourself

Delete template?

Save as template?